Zahran Ahmed, El-Husseini Amr, Shoker Ahmed
Royal University Hospital, Department of Medicine, Division of Nephrology, University of Saskatchewan, Saskatoon, Sask., Canada.
Am J Nephrol. 2007;27(2):197-205. doi: 10.1159/000100907. Epub 2007 Mar 15.
With the increasing knowledge that estimation of glomerular filtration rate (GFR) from serum creatinine (Scr) has limited value, researchers have developed new equations based on serum cystatin C (Cys C).
To compare the performance of serum Cys C and Cys C-based GFR equations to Scr and Scr-based GFR equations.
A Medline literature search for studies in English.
Fourteen studies in kidney transplant patients and 29 in patients with native kidney disease were identified. 70% of studies on transplants favored Cys C over Scr while 60% favored serum Cys C over Scr in patients with native kidney disease. Three studies in transplant patients and 6 in patients with native kidney disease compared the performances of Cys C- and Scr-based equations. 70% of the studies performed on transplantation favored Cys C, while 85% the studies performed in native kidney diseases showed superiority of Cys C-based equations.
A large number of studies favor Cys C over Scr for the estimation of GFR. Still, many reports show no superiority of Cys C over Scr. Consistent with this, more studies are needed to study the performance of Cys C-based GFR equations.
随着人们越来越认识到根据血清肌酐(Scr)估算肾小球滤过率(GFR)的价值有限,研究人员基于血清胱抑素C(Cys C)开发了新的方程。
比较血清Cys C和基于Cys C的GFR方程与Scr和基于Scr的GFR方程的性能。
对英文研究进行Medline文献检索。
确定了14项关于肾移植患者的研究和29项关于原发性肾病患者的研究。70%的肾移植研究更倾向于Cys C而非Scr,而在原发性肾病患者中,60%的研究更倾向于血清Cys C而非Scr。3项关于肾移植患者的研究和6项关于原发性肾病患者的研究比较了基于Cys C和基于Scr的方程的性能。70%的肾移植研究倾向于Cys C,而在原发性肾病患者中进行的研究有85%表明基于Cys C的方程更具优势。
大量研究表明在估算GFR方面Cys C优于Scr。然而,许多报告显示Cys C并不比Scr更具优势。与此一致的是,需要更多研究来探讨基于Cys C的GFR方程的性能。